US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist
  • 111.570
  • +2.030+1.85%
Close Jul 26 16:00 ET
  • 111.570
  • 0.0000.00%
Post 20:02 ET
7.04BMarket Cap23.10P/E (TTM)

Jazz Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jazz Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Jul 31, 2024

Revenue(YoY)

1.00B

+4.96%
EPS(YoY)

1.45

-4.81%
Analyst Rating

Strong Buy

Jul 26, 2024

Jazz Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.044B--
Jul 31, 20242024/Q2-- / 1.005B--
May 1, 20242024/Q1901.983M / 954.321M--
Feb 28, 20242023/Q41.012B / 1.005B--
Nov 8, 20232023/Q3972.140M / 969.338M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.044B--
Jul 31, 20242024/Q2-- / 1.005B--
May 1, 20242024/Q1901.983M / 954.321M--
Feb 28, 20242023/Q41.012B / 1.005B--
Nov 8, 20232023/Q3972.140M / 969.338M--

Unlock Free Earnings Estimates

Jazz Pharmaceuticals Earnings Reports

  • Jazz Pharmaceuticals | 10-Q: Quarterly report

    May 2 07:43 ET

  • Jazz Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Apr 26 16:45 ET

  • Jazz Pharmaceuticals | 10-K: Annual report

    Feb 28 22:42 ET

  • Jazz Pharmaceuticals: Q3 2023 Earnings Report

    Nov 8, 2023 16:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 26, 2024

    Strong Buy

    • Buy

      87.50%

    • Hold

      12.50%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg